Back to Search
LESLIE GORDON, MD
MD
Ophthalmology Physician
NPI: 1104038231IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
243820(NY)25MA08313100(NJ)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
NEW YORK MEDICAL COLLEGE
Class of 2003
Research & Publications (20)
Has the pendulum swung too far? The impact of missed abdominal injuries in the era of nonoperative management.
PMID 19655598·Am Surg·2009
8-other
[The effect of apoptosis inductor dexamethasone on the energy exchange and ultrastructure of plant cells].
PMID 19637758·Tsitologiia·2009
8-other
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
PMID 19603344·Leuk Lymphoma·2009
8-other
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process.
PMID 19592015·J Surg Res·2009
8-other
Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings.
PMID 19536149·J Invest Dermatol·2009
8-other
Interpretation of clinical guidelines for poisoned patients: positive and negative effects of standard phrases used in TOXBASE.
PMID 19517102·Eur J Clin Pharmacol·2009
8-other
Improved methodology for assessment of mRNA levels in blood of patients with FMR1 related disorders.
PMID 19505339·BMC Clin Pathol·2009
8-other
Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).
PMID 19494199·Invest Ophthalmol Vis Sci·2009
8-other
NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
PMID 19435914·Cancer Res·2009
7-preclinical
Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells.
PMID 19420345·Invest Ophthalmol Vis Sci·2009
7-preclinical
PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
PMID 19417023·Clin Cancer Res·2009
8-other
The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathy.
PMID 19391086·Am J Perinatol·2009
4-observational
Analysis of acuity trends using Resource Intensity Weights via the CIHI Portal.
PMID 19380913·Stud Health Technol Inform·2009
8-other
8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors--part II.
PMID 19286377·Bioorg Med Chem Lett·2009
4-observational
Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor.
PMID 19285469·Neuron·2009
7-preclinical
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.
PMID 19264918·Blood·2009
4-observational
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study.
PMID 19255334·J Clin Oncol·2009
3-trial
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.
PMID 19255322·J Clin Oncol·2009
3-trial
Integrating resilience thinking and optimisation for conservation.
PMID 19665820·Trends Ecol Evol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3777 BROADWAY
NEW YORK, NY 10032 - Phone
- (212) 926-0336
Quick Facts
- NPI
- 1104038231
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile